Farmax India Limited Reports Audited Standalone and Consolidated Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014
For the year, the standalone company reported net income from operations of INR 174.054 million against INR 519.235 million a year ago. Loss from operations before other income and exceptional items was INR 92.21 million against INR 243.713 million a year ago. Loss from ordinary activities before tax was INR 88.43 million against INR 1,265.924 million a year ago. Net loss for the period was INR 88.43 million against INR 1,273.152 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.22 against INR 3.55 a year ago.
For the year, the consolidated company reported net income from operations of INR 174.054 million against INR 519.235 million a year ago. Loss from operations before other income and exceptional items was INR 92.618 million against INR 244.082 million a year ago. Loss from ordinary activities before tax was INR 88.839 million against INR 1,437.567 million a year ago. Net loss for the period was INR 88.839 million against INR 1,444.795 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 4.03 against loss of INR 4.03 a year ago.